Lakeshore Biopharma Co Stock Performance
| LSBCF Stock | 0.84 0.01 1.18% |
LakeShore Biopharma has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.37, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, LakeShore Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding LakeShore Biopharma is expected to be smaller as well. LakeShore Biopharma right now secures a risk of 3.51%. Please verify LakeShore Biopharma Co downside variance, rate of daily change, and the relationship between the maximum drawdown and skewness , to decide if LakeShore Biopharma Co will be following its current price movements.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in LakeShore Biopharma Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, LakeShore Biopharma is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 246.6 M | |
| Total Cashflows From Investing Activities | -17 M |
LakeShore | Build AI portfolio with LakeShore Stock |
LakeShore Biopharma Relative Risk vs. Return Landscape
If you would invest 82.00 in LakeShore Biopharma Co on October 8, 2025 and sell it today you would earn a total of 2.00 from holding LakeShore Biopharma Co or generate 2.44% return on investment over 90 days. LakeShore Biopharma Co is currently producing 0.0996% returns and takes up 3.5144% volatility of returns over 90 trading days. Put another way, 31% of traded stocks are less volatile than LakeShore, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
LakeShore Biopharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LakeShore Biopharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LakeShore Biopharma Co, and traders can use it to determine the average amount a LakeShore Biopharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0284
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | LSBCF | Huge Risk |
| Negative Returns |
Based on monthly moving average LakeShore Biopharma is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LakeShore Biopharma by adding it to a well-diversified portfolio.
LakeShore Biopharma Fundamentals Growth
LakeShore Stock prices reflect investors' perceptions of the future prospects and financial health of LakeShore Biopharma, and LakeShore Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LakeShore Stock performance.
| Revenue | 614.96 M | ||||
| EBITDA | (48.54 M) | ||||
| Total Debt | 414.4 M | ||||
| Cash Flow From Operations | (120.98 M) | ||||
| Total Asset | 1.37 B | ||||
| Retained Earnings | (2.41 B) | ||||
About LakeShore Biopharma Performance
By analyzing LakeShore Biopharma's fundamental ratios, stakeholders can gain valuable insights into LakeShore Biopharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LakeShore Biopharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LakeShore Biopharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about LakeShore Biopharma performance evaluation
Checking the ongoing alerts about LakeShore Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LakeShore Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LakeShore Biopharma has some characteristics of a very speculative penny stock | |
| LakeShore Biopharma had very high historical volatility over the last 90 days | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 614.96 M. Net Loss for the year was (99.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LakeShore Biopharma generates negative cash flow from operations |
- Analyzing LakeShore Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LakeShore Biopharma's stock is overvalued or undervalued compared to its peers.
- Examining LakeShore Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LakeShore Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LakeShore Biopharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LakeShore Biopharma's stock. These opinions can provide insight into LakeShore Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for LakeShore Stock analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |